Iradimed Corp
(IRMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 841 | 500 | 316 | 124 | -233 |
| Depreciation Amortization | 428 | 1,309 | 971 | 633 | 287 |
| Accounts receivable | 490 | -202 | 71 | -211 | 47 |
| Accounts payable and accrued liabilities | -81 | -523 | -334 | -409 | -320 |
| Other Working Capital | -171 | -1,121 | -1,248 | -1,701 | -604 |
| Other Operating Activity | 76 | 3,454 | 2,239 | 1,671 | 639 |
| Operating Cash Flow | $1,584 | $3,416 | $2,015 | $107 | $-185 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 250 | -199 | 1,174 | 949 | 179 |
| PPE Investments | -38 | -825 | -682 | -420 | -241 |
| Investing Cash Flow | $212 | $-1,024 | $492 | $528 | $-62 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 96 | 76 | 50 | 50 | 33 |
| Common Stock Repurchased | N/A | -1,819 | -1,819 | -1,553 | N/A |
| Other Financing Activity | -4 | -158 | -45 | -45 | -44 |
| Financing Cash Flow | $92 | $-1,900 | $-1,814 | $-1,549 | $-11 |
| Beginning Cash Position | 18,206 | 17,714 | 17,714 | 17,714 | 17,714 |
| End Cash Position | 20,093 | 18,206 | 18,406 | 16,801 | 17,457 |
| Net Cash Flow | $1,887 | $492 | $692 | $-913 | $-257 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,584 | 3,416 | 2,015 | 107 | -185 |
| Capital Expenditure | -38 | -825 | -682 | -420 | -241 |
| Free Cash Flow | 1,546 | 2,591 | 1,333 | -314 | -425 |